A Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in a '1+2' Sequential Schedule With Bivalent Oral Poliovirus Vaccine in 2-month-old Infants
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
Most Recent Events
- 06 Feb 2019 New trial record